Ori Biotech launches IRO platform at ISCT 2024, automating, digitizing, and standardizing CGT manufacturing to enhance efficiency and speed.
Ori Biotech Ltd. launched its IRO platform at ISCT 2024, addressing challenges in cell & gene therapy (CGT) manufacturing. The platform automates, digitizes, and standardizes processes, reducing labor by 70%, cutting processing times by 25%, and accelerating tech transfer times. IRO aims to help organizations bring products to patients at scale, potentially shaving years off therapy development timelines.
May 29, 2024
5 Articles